Birth Control :: Lybrel contraceptive pill – take 365 days a year

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (FDA) has approved the oral contraceptive Lybrel? (90 mcg levonorgestrel/20 mcg ethinyl estradiol) tablets for the prevention of pregnancy in women who elect to use oral contraceptives and who have no known contraindications for this method of contraception.

Asthma :: Persistent and severe asthma associated with obesity

After analyzing results of a survey of more than 3,000 adults with asthma, researchers at Emory Crawford Long Hospital have found that obese patients with asthma are more likely to have severe asthma when compared to those who are not overweight.

Avandia :: Safety alert on Avandia – a timely action of FDA

The U.S. Food and Drug Administration (FDA) issued a safety alert on Avandia, diabetes drug approved to treat type 2 diabetes. I believe safety alert on Glaxo’s diabetes drug Avandia is a timely action by US FDA health agency, remarked Dr. Anil Singhal.

Diabetes :: Diabetics in nursing homes need improved care

Ohio University College of Osteopathic Medicine researchers find that elderly diabetics in extended-care facilities need improved treatment protocols for diabetes. Current standards of care fail to meet American Diabetes Association standards for outpatient diabetics.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack